United States · FDA National Drug Code directory
lurasidone hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68180-670_8d77b0dd-8cc2-44da-afed-1e5cb75bed99
- Product NDC
- 68180-670
- Form
- TABLET
- Composition / generic term
- lurasidone hydrochloride
- Labeler
- Lupin Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230220
- Source listing expiry
- 20261231
Source-listed ingredients
- LURASIDONE HYDROCHLORIDE — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (68180-670-06) · 68180-670-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →